Sorrento Therapeutics competitors and similar companiesClear all
Sorrento Therapeutics's competitors and similar companies include Celyad, Alnylam Pharmaceuticals, Luna Innovations and Kuros Biosciences.
 Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
|  Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. |  Luna Innovations Luna Innovations is a company that specializes in optical technologies, fiber optic tests, measurement, and control products. |  Kuros Biosciences Kuros Biosciences engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases internationally. | |
Founding Date | Founding Date 2006 | Founding Date 2007 | Founding Date 2002 | Founding Date 1990 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ San Diego, US | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations Roanoke, US HQ Köln, DE Farnborough, GB Portishead, GB Winfrith Newburgh, GB Ann Arbor, US Atlanta, US see more | Locations Schlieren, CH HQ Bilthoven, NL Burlington, US | |
Employees | Employees 31019% decrease | Employees 95 | Employees 1,32324% increase | Employees 3852% decrease | Employees 58 |
Valuation ($) | Valuation ($) 558.8 m | Valuation ($) 30.8 m | Valuation ($) 27.1 b | Valuation ($) 282.6 m | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 2.4 k | Twitter followers 16 k | Twitter followers 644 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) 27 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1 | Average likes per tweet (last 30 days) 9.1 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 401759 | Alexa Website Rank 460272 | Alexa Website Rank 460935 | Alexa Website Rank 437585 | Alexa Website Rank 699412 |
Employee Rating | Employee Rating 3.4 | Employee Rating 3.5 | Employee Rating 4.2 | Employee Rating 3.2 | Employee Rating 5 |
Financial | |||||
Revenue (est.) | Revenue (est.) $52.9m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $844.3m (FY, 2021) | Revenue (est.) $87.5m (FY, 2021) | Revenue (est.) CHF13.8m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $115m (FY, 2021) | Cost of goods $36m (FY, 2021) | Cost of goods CHF1.4m (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit €5.8m (FY, 2021) | Gross profit N/A | Gross profit $51.6m (FY, 2021) | Gross profit CHF12.7m (FY, 2021) |
Net income | Net income ($429.1m) (FY, 2021) | Net income (€26.5m) (FY, 2021) | Net income ($852.8m) (FY, 2021) | Net income $1.4m (FY, 2021) | Net income (CHF7.5m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 42.6m | Total funding raised N/A | Total funding raised $ 1.5b | Total funding raised $ 13.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
95
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
View companyAlnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
View companyLuna Innovations
HQ
Roanoke, US
Employees
385↓ 2% decrease
Luna Innovations is a company that specializes in optical technologies, fiber optic tests, measurement, and control products.
View companyKuros Biosciences
HQ
Schlieren, CH
Employees
58
Kuros Biosciences engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases internationally.
View company